AMPK信号调节了表皮质血栓内皮质瘤细胞生长的过程
Ryan Kanai1, Sarah McMullan1, Pukar Baniya1
1Department of Molecular and Cellular Physiology, Albany Medical College, Albany, NY 12208, USA.
AMP激活蛋白激酶 (AMPK) 激活通过增加TAZ-CAMTA1表达和抑制mTOR信号传递来抑制表皮质血管内皮瘤 (EHE) 的生长. 这种双重作用凸显了AMPK作为这种罕见的血管肉瘤的潜在治疗点.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 皮质血管内皮瘤 (EHE) 是一种罕见的血管肉瘤,治疗结果不佳.
- 产生TAZ-CAMTA1蛋白的WWTR1-CAMTA1基因融合是EHE的一个关键驱动因素.
- 向TAZ-CAMTA1是EHE治疗的一个有希望的策略.
研究的目的:
- 研究AMP激活蛋白激酶 (AMPK) 在调节TAZ-CAMTA1活性和EHE细胞生长中的作用.
- 探索AMPK激活在EHE中的治疗潜力.
主要方法:
- 利用NIH3T3和HEK293细胞系研究TAZ-CAMTA1通过AMPK的调节.
- 将药理学AMPK激活剂给EHE细胞系.
- 评估TAZ-CAMTA1的表达,活性和细胞增殖.
- 研究了AMPK对mTOR信号传递的影响.
主要成果:
- 在正常细胞系中,AMPK激活抑制了TAZ-CAMTA1活动.
- 在EHE细胞中,AMPK激活意外地增加了TAZ-CAMTA1的表达和活性,与细胞生长减少相关.
- AMPK激活抑制了mTOR信号传递,这也抑制了EHE细胞的增殖.
- 确定了AMPK作用的双重机制:TAZ-CAMTA1诱导和mTOR抑制.
结论:
- 通过促进TAZ-CAMTA1的表达和抑制mTOR信号传递,AMPK激活在EHE中发挥抗癌作用.
- AMPK代表了表皮质血管内皮瘤的潜在治疗标.
- 这些发现支持使用mTOR抑制剂作为EHE的治疗策略.
更多相关视频
09:32Light-mediated Reversible Modulation of the Mitogen-activated Protein Kinase Pathway during Cell Differentiation and Xenopus Embryonic Development
Published on: June 15, 2017
11:13Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
Published on: June 9, 2023
相关概念视频
Regulation of Angiogenesis and Blood Supply
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Mitogens and the Cell Cycle
cAMP-dependent Protein Kinase Pathways
